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The nature of signals transmitted by two Fc7 receptors (Fc72R for IgG2 and Fc~'~/y2R for both IgG2 and 
IgGl) on guinea pig polymorphonuclear leukocytes was investigated. The specific binding of hen ovalbumin 
(OA)-complexed IgGl antibody to FcT~/y2R did not seem to trigger the release of [3H]arachidonic acid from 
the cells prelabeled with [3H]arachidonic acid. In contrast, marked release occurred on the binding of OA- 
complexed IgG2 antibody to the cells. This reaction was not inhibited, but rather enhanced, by the Fab' 
of a monoclonal antibody to Fcyl/yzR. Therefore, a signal for the activation of the arachidonic acid meta- 
bolic cascade was found to be transmitted by Fc72R, but scarcely by Fcy~/72R. 
Arachidonic acid: Fcy receptor; Anti-Fc7 receptor antibody; Immune complex; Polymorphonuclear leukocyte 
1. INTRODUCTION 
The Fc7 receptors are the surface proteins of 
phagocytes which bind specifically to the Fc por- 
tions of antigen-complexed IgG antibodies, 
resulting in the elicitation of various functions of 
the cell such as the respiratory burst, phagocytosis 
and activation of the arachidonic acid metabolic 
cascade [1-4]. Recently, the variety of FcyRs on a 
single phagocytic ell was made clear with human 
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and murine cells [5]. We also demonstrated that 
guinea pig polymorphonuclear leukocytes express 
two distinct types of FcyR; one (FcyzR) is specific 
for IgG2 alone and the other (Fcyl/yzR) is specific 
for both IgG1 and IgG2 [6]. 
Recently, we found that a signal for the activa- 
tion of the arachidonic acid metabolic ascade was 
transmitted by FcTzR, but scarcely by FCyl/y2R. 
This finding is reported in this paper. 
2. MATERIALS AND METHODS 
2.1. Materials 
Guinea pig PMNs were isolated 15 h after in- 
traperitoneal injection of casein, and purified as 
described in [7]. Guinea pig IgG1 and IgG2 anti- 
OA antibodies were highly purified from hyperim- 
mune serum, as described in [8]. The monoclonal 
antibody (VIA2) IgG1) to guinea pig macrophage 
Fcy~/y2R used was a secreting product of the 
hybridoma cells (VIA2) obtained by cell fusion of 
the splenic cells of a mouse immunized with 
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guinea-pig intraperitoneal macrophages with 
murine myeloma cells. The antibody was highly 
purified and its Fab'  was prepared as described in 
[9]. 
2.2. Measurement of the release of 
l~H]arachidonic acid from the prelabeled 
PMNs 
PMNs (2.5 × 10 s cells) were incubated with 10 
/~Ci of [5,6,8,9,11,12,14,15-3H]arachidonic acid
(New England Nuclear, Boston, MA) for 15 min at 
37°C in 25 ml of Eagles minimum essential 
medium supplemented with 20 mM Hepes and 
0.1% bovine serum albumin, pH 7.4. Following 
washing with KRPG, the cells were suspended in 
KRPG at 3 x l0  7 cells/ml. 
The PMNs thus prelabeled (6 x 106 cells) were 
stimulated with OA-complexed IgG1 or IgG2 an- 
tibody (OA-IgG1 or OA-IgG2) in 1 ml of KRPG 
for 15 rain at 37°C, and then centrifuged. The 
amount of [3H]arachidonic acid released from the 
cells was determined by measuring radioactivity of 
the supernatant in a scintillation counter. These 
procedures were essentially the same as those 
described by Hirata et al. [10]. As a control, PMNs 
were similarly incubated, but without OA-IgG. 
The amount of [3H]arachidonic acid released was 
expressed as a percentage of that of the cells used, 
and the results were shown by the release nhanced 
by OA-IgG; the spontaneous release was about 1 °70 
in most of the experiments. 
3. RESULTS 
3.1. The release of arachidonic acid with 
antigen-complexed lgG antibodies 
Phagocytes including PMNs release arachidonic 
acid on stimulation with immune complexes [3,4]. 
To investigate the possible roles of Fcy2R and 
FC '~ l /y2R on  guinea pig PMNs in the reaction, the 
cells were stimulated with OA-IgG2 and OA-IgG1 
which had been prepared by reacting each an- 
tibody with the antigen at a molar antigen to an- 
tibody ratio of 0.1. The stimulation with OA-IgG2 
elicited a marked release of [3H]arachidonic acid 
from the prelabeled cells in a time-dependent man- 
ner (fig.l). This ability of OA-IgG2 was of the 
same order of magnitude as that of 1 /~M 
ionomycin which is a CaZ+-specific onophore [11]; 
at this concentration, ionomycin exhibited the 
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Fig.1. Time courses of the arachidonic acid release by 
PMNs stimulated with OA-IgG1, OA-IgG2 and 
ionomycin, [3H]Arachidonic acid-prelabeled PMNs (6 
× 10 6 cells) were incubated with 200/zg/ml of OA-IgGI 
(0), OA-IgG2 (e) or 1 /zM ionomycin (,x) for varying 
periods at 37°C. After incubation, the amounts of 
released [3H]arachidonic acid were measured. Each 
value expresses the total amount of released 
[3H]arachidonic acid without subtracting the spon- 
taneous release. 
highest activity. The amount of [3H]arachidonic 
acid released for 15 min increased with increasing 
OA-IgG2 up to 200/zg; the amount of complex was 
expressed in terms of IgG2 antibody used for 
preparing the complex (fig.2). 
In contrast, the ability of OA-IgG1 to elicit 
the release of [3H]arachidonic acid was markedly 
low even when the cells were reacted with excessive 
amounts of the complex (figs 1 and 2). Though the 
ability of OA-IgG1 was further tested with the 
complexes prepared by reacting 200 #g IgG1 an- 
tibody with OA at varying molar antigen to an- 
tibody ratios from 0.025 to 0.5, the amounts of 
released [3H]arachidonic acid were remarkably 
small, relative to those with OA-IgG2. These 
results indicate that the Fcyl/yzR-mediated 
stimulation of PMNs scarcely induces any in- 
tracellular event(s) leading to the activation of the 
arachidonic acid metabolic ascade. On the other 
hand, the highest activity of OA-IgG2 was shown 
by the complexes formed at molar antigen to an- 
tibody ratios of 0.1-0.5 (not shown). 
The release of [3H]arachidonic acid by the OA- 
IgG2-stimulated PMNs was completely inhibited 
either by 5 /zM p-bromophenacyl bromide (a 
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Fig.2. The arachidonic acid release by PMNs stimulated 
with OA-IgG1 and OA-IgG2. [3H]Arachidonic acid- 
prelabeled PMNs (6 x 10 6 cells) were incubated with 
varying amounts of OA-IgG1 (©) or OA-IgG2 (e) for 
15 min at 37°C. After incubation, the amounts of re- 
leased [~H]arachidonic a id were measured. 
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Fig.3. Effect of the Fab' of anti-Fcy]/y2R antibody on 
the arachidonic acid release by OA-IgG2-stimulated 
PMNs. [3H]Arachidonic acid-prelabeled PMNs (6 x 106 
cells) were incubated with or without 10/~g of the Fab' 
of anti-Fcy~/yzR antibody (VIA2 Fab') for 1 h at 4°C, 
and further incubated in the presence (open bars) or 
absence (hatched bars) of 200/~g of OA-IgG2 for 15 rain 
at 37°C. After incubation, the amounts of released 
[3H]arachidonic acid were measured. Each value 
represents he mean + SD. 
phospho l ipase  A2  inhibitor) or by 0.5 mM EGTA 
(not shown). Thus, arachidonic acid release by the 
stimulation with OA-IgG2 may be a direct result of 
the initial activation of intrinsic phospholipase A2 
activity. On the other hand, 0.5 /~g/ml of 
cytochalasin B did not change the levels of 
[3H]arachidonic acid release from the OA-IgG2- 
and OA-IgGl-stimulated PMNs (not shown). 
Since cytochalasin B inhibits phagocytic activity 
[12], the results obtained on arachidonic acid 
release may be independent of the phagocytic pro- 
cess. 
3.2. The effect of anti-Fcy~/y2R antibody on the 
reaction with OA-IgG2 
The results described in the preceding section 
strongly suggest hat the triggering signal for the 
arachidonic acid release is transmitted by Fcy2R, 
but scarcely by Fcy]/yzR. To confirm further this 
possibility, the effect of a monoclonal antibody to 
macrophage Fcy~/y2R. (VIA2 IgG1) on the release 
of [3H]arachidonic acid with OA-IgG2 was ex- 
amined because the antibody binds cross-reactively 
to the Fcy]/yzR on PMN cells [6]. 
When the prelabeled PMNs were preincubated 
with the Fab'  of VIA2 lgG1 and then reacted with 
OA-IgG2, the release of [3H]arachidonic acid was 
not inhibited, but rather enhanced 22-36% (fig.3). 
This suggests that the release of [3H]arachidonic 
acid with OA-IgG2 is mediated by Fcy2R alone, 
and also that the binding of OA-IgG2 through 
Fcy~/y~R, which occurs concurrently with the bin- 
ding through Fcy2R, lowers competitively the abili- 
ty of Fcy2R to elicit the arachidonic acid release. 
4. DISCUSSION 
The results presented in this paper demonstrate 
that two types of FcyR on the surface of PMN cells 
are distinguishable from each other with regard to 
function. The specific binding of OA-IgG2 to 
FcyzR activated the intrinsic phospholipase A2 ac- 
tivity, leading to the enhanced release of 
arachidonic acid. On the other hand, the specific 
binding of OA-IgG1 or OA-IgG2 to Fcy~/y2R did 
not significantly trigger any enhanced release of 
arachidonic acid. As the number of FCyl/y2R is 2 
x 104 molecules per PMN cell, which is about one- 
quarter of that of Fcy2R molecules [6], the failure 
of OA-IgG to trigger arachidonic acid release 
through Fcyl/yzR might be due to the small 
number of FCyl/yzR molecules per cell. However, 
the inhibition of the Fcy~/y2R-mediated binding of 
OA-IgG2 by the Fab'  of anti-Fcy]/y2R antibody 
resulted in the enhancement of arachidonic acid 
release with the complex, indicating that FCyl/y2R 
31 
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does not cooperate with FcTzR in the reaction, but 
depresses the FcTzR-mediated reaction. 
We, furthermore, confirmed that the stimula- 
tion of PMNs with OA-IgG1 could elicit both the 
Oz--generating and phagocytic activities, as in the 
case of OA-IgG2 (data to be published elsewhere). 
It, therefore, seems very probable that in differing 
from Fc72R, Fc71/yzR cannot transmit sufficient 
signal for the activation of phospholipase A2 ac- 
tivity, and that these two FcTRs transmit two 
unrelated, distinct signals to the cells, upon 
specific binding of appropriate immune com- 
plexes. 
Recently, a signal for the activation of the 
arachidonic acid metabolic cascade was reported 
to be transmitted by Fcy2bR, but not by Fc72bR, on 
the surface of a murine macrophage cell line, 
P388D~ cells [4]. In this respect, the FcTzR and 
Fcy~/yzR that we studied resemble Fcy2bR and 
FCyzaR on P388D1 cells, respectively. 
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